Trinity Biotech plc Reported Earnings
Tuesday, July 1, 2025 at 9:00 AM ET
Trinity Biotech plc (TRIB) reported a loss of $0.48 per share on revenue of $7.57 million for the first quarter ended March 2025. The consensus revenue estimate was revenue of $16.00 million. Revenue fell 48.52% compared to the same quarter a year ago.
Trinity Biotech PLC develops, acquires, manufactures & markets medical diagnostic products for clinical laboratory & point-of-care of diagnostic market. Its products are used to detect autoimmune, infectious, diabetes and disorders of liver & intestine.
Earnings Whisper Grade
Power Rating
-
-
Reported Earnings
$-0.48
Earnings Whisper®
-
Consensus Estimate
-
Earnings Surprise
Earnings Growth
Reported Revenue
$7.57 Mil
Revenue Estimate
$16.00 Mil
Revenue Surprise
Revenue Growth